EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RND Pump-Mediated Efflux of Amotosalen, a Compound Used in Pathogen Inactivation Technology to Enhance Safety of Blood Transfusion Products, May Compromise Its Gram-Negative Anti-Bacterial Activity

Alex B Green, Lucius Chiaraviglio, Katherine A Truelson, Katelyn E Zulauf, Meng Cui, Zhemin Zhang, Matthew P Ware, Willy A Flegel iD, Richard L Haspel, Edward W Yu, James E Kirby iD

mSphere · 2023

DOI: 10.1128/msphere.00673-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSphere, 2023. Verfasst von Alex B Green und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Membrane Transport Proteins, Furocoumarins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases, HHS | NIH | NIH Clinical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathogen inactivation is a strategy to enhance the safety of transfused blood products. We identify the compound, amotosalen, widely used for pathogen inactivation, as a bacterial multidrug efflux substrate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane Transport ProteinsFurocoumarinsBacterial ProteinsEscherichia coliGram-Negative BacteriaBlood TransfusionCell Division

Stichwörter der Autor:innen

Acinetobacter baumanniiEshcerichia coliPseudomonasRNDadeABCamotosalenantimicrobial resistanceeffluxmexXYmultidrug resistancepathogen inactivationpsoralen

Substanzen

amotosalenMembrane Transport ProteinsBacterial ProteinsFurocoumarins

Autor:innen und Institutionen

  • Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Pharmaceutical Sciences, School of Pharmacy, Bouvé College of Health Sciences, Northeastern University, Boston, Massachusetts, USA.
  • Department of Pharmacology, Case Western Reserve University Medical Center, Cleveland, Ohio, USA.
  • Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health Bethesda, Maryland, USA.

ORCID-Profile: Willy A Flegel, James E Kirby

Förderung

  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases
  • HHS | NIH | NIH Clinical Center

Zitieren

APA

Green, A. B., Chiaraviglio, L., Truelson, K. A., Zulauf, K. E., Cui, M., Zhang, Z., Ware, M. P., Flegel, W. A., Haspel, R. L., Yu, E. W., & Kirby, J. E. (2023). RND Pump-Mediated Efflux of Amotosalen, a Compound Used in Pathogen Inactivation Technology to Enhance Safety of Blood Transfusion Products, May Compromise Its Gram-Negative Anti-Bacterial Activity. mSphere. https://doi.org/10.1128/msphere.00673-22

Vancouver

Green AB, Chiaraviglio L, Truelson KA, Zulauf KE, Cui M, Zhang Z, et al. RND Pump-Mediated Efflux of Amotosalen, a Compound Used in Pathogen Inactivation Technology to Enhance Safety of Blood Transfusion Products, May Compromise Its Gram-Negative Anti-Bacterial Activity. mSphere. 2023. doi:10.1128/msphere.00673-22

BibTeX
@article{Green2023,
  author = {Green, Alex B and Chiaraviglio, Lucius and Truelson, Katherine A and Zulauf, Katelyn E and Cui, Meng and Zhang, Zhemin and Ware, Matthew P and Flegel, Willy A and Haspel, Richard L and Yu, Edward W and Kirby, James E},
  title = {RND Pump-Mediated Efflux of Amotosalen, a Compound Used in Pathogen Inactivation Technology to Enhance Safety of Blood Transfusion Products, May Compromise Its Gram-Negative Anti-Bacterial Activity},
  journal = {mSphere},
  year = {2023},
  doi = {10.1128/msphere.00673-22}
}
Kostenlos starten →